OncoSpear ApS: Financial statements 2021
CVR: 42093734
Source: annual report 2021, Danish Business Authority
01/02/2021 – 31/12/2021
OncoSpear ApS (CVR 42093734) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -25,963 and a net result of DKK -26,170. Equity in the 2021 report amounted to DKK 23,830. The solvency ratio was 71.4%.
- Gross Profit
- DKK -25,963
- Profit/Loss
- DKK -26,170
- Equity
- DKK 23,830
- Total Assets
- DKK 33,373
Official annual report
Find more companies like OncoSpear ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of February 1, 2021, Jens Kristian Damsgaard has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Søren Kragh Moestrup has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Holger Jon Møller has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Anders Etzerodt has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Toby Lawrence has joined the board of directors of OncoSpear ApS.
As of February 1, 2021, Niels Jonas Heilskov Graversen is registered as director of OncoSpear ApS.
OncoSpear ApS was founded on February 1, 2021.
About OncoSpear ApS
OncoSpear ApS is a Danish company of the type Anpartsselskab based in Hinnerup, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Geert Gilbert Tackaert and Niels Jonas Heilskov Graversen. The company is owned by SPICA THERAPEUTICS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 2,927,421 and a net result of DKK -821,765 compared with DKK -6,461,139 the year before. Equity in the 2025 report amounted to DKK 569,861.